5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.39▼ | 7.43▼ | 7.43▼ | 7.32▲ | 7.57▼ |
MA10 | 7.44▼ | 7.43▼ | 7.43▼ | 7.11▲ | 7.65▼ |
MA20 | 7.52▼ | 7.57▼ | 7.59▼ | 7.34▲ | 7.79▼ |
MA50 | 7.59▼ | 7.67▼ | 7.64▼ | 7.53▼ | 8.51▼ |
MA100 | 7.70▼ | 7.75▼ | 7.77▼ | 7.69▼ | 20.92▼ |
MA200 | 7.91▼ | 8.14▼ | 8.55▼ | 8.49▼ | 253.65▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.025▼ | -0.012▼ | -0.010▼ | 0.045▲ | 0.089▲ |
RSI | 46.607▼ | 46.209▼ | 46.103▼ | 51.973▲ | 44.234▼ |
STOCH | 40.650 | 18.576▼ | 18.576▼ | 50.150 | 29.549 |
WILL %R | -67.213 | -78.022▼ | -78.022▼ | -37.342 | -70.270 |
CCI | -61.427 | -83.241 | -83.241 | 72.970 | -54.182 |
CDL | $ADXN Marubozu Candlestick Pattern Detected | Set Alert |
Thursday, April 17, 2025 04:00 AM
Switzerland-based Addex Therapeutics, a biopharma developing a portfolio of novel small molecule allosteric modulators for neurological disorders, has announced an update on its Phase II asset, ...
|
Wednesday, April 16, 2025 10:25 PM
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 17, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage ...
|
Wednesday, April 16, 2025 10:23 PM
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 17, 2025 - Addex Therapeutics(SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/04/25 | 7.30 | 7.50 | 7.29 | 7.50 | 3,864 |
16/04/25 | 7.43 | 7.43 | 7.43 | 7.43 | 1,353 |
15/04/25 | 7.43 | 7.43 | 7.43 | 7.43 | 1,299 |
14/04/25 | 7.02 | 8.09 | 6.70 | 6.97 | 28,417 |
11/04/25 | 7.00 | 7.57 | 7.00 | 7.285 | 6,979 |
10/04/25 | 6.91 | 6.91 | 6.8698 | 6.8698 | 4,159 |
09/04/25 | 6.51 | 6.51 | 6.51 | 6.51 | 3,910 |
08/04/25 | 6.9456 | 7.655 | 6.51 | 6.51 | 32,314 |
07/04/25 | 6.80 | 7.39 | 6.60 | 7.16 | 8,799 |
04/04/25 | 7.11 | 7.60 | 7.04 | 7.43 | 25,336 |
|
|
||||
|
|
||||
|
|